chinadaily.com.cn
|
english.gov.cn
Home
Policies
News
Specials
Topics
Regions
Home
>
Topics
>
Medical Products
>
Drugs
NMPA, Ministry of Public Security, National Health Commission issues the Announcement on the Inclusion of Oxycodone-Containing Compound Preparations in the Management of Psychotropic Substances
NMPA issues the Announcement on Issues Pertaining to the Implementation of Drug Standards in the Consistency Evaluation of the Quality and Efficacy of Generic Drugs
Provisions for Supervision of Drug Distribution
Provisions for In-vitro Diagnostic Reagent Registration
Provisions for Drug Registration
Provisions for Drug Insert Sheets and Labels
Good Manufacturing Practice for Drugs (2010 Revision)
NMPA issues the Announcement on Cancellation of 16 Certification Items (Second Batch)
General Office of the State Council issues the Opinions on Establishing a Team of Professionalized & Specialized Drug Inspectors
Main responsibilities of the National Medical Products Administration
NMPA issues the Announcement on the Requirements for Dossiers and Samples for Verification and Inspection of Specifications for Overseas New Drugs Urgently Needed in Clinical Settings
NMPA issues the Announcement on Issues Concerning the Further Improvement of Drug-related Associated Review & Approval and Supervision
<
1
2
MOST POPULAR
1
A guide to working and living in China as business expatriates
2
Mainland to expand use of travel permits for Taiwan residents
3
Milestones of China's journey to space
4
China leads world in top sci-tech clusters
5
Better biz climate prioritized
Editors' Picks
Infographic:
Foreigners in China to enjoy more convenient payment services
Infographic:
China actively supports young people in S&T innovation
Infographic:
Health literacy rate up in 2023
Video:
A look at China's economic data in Q1 of 2024
Infographic:
A guide to working and living in China as business expatriates
LEAVE YOUR MESSAGE
*Your E-mail Address
Copyright©2024 China Daily. All rights reserved.
京ICP备13028878号-6
京公网安备 11010502032503号